🩺 Article Summary
Age-related macular degeneration (AMD) poses a major risk to eye health among older adults, especially in its common dry form. A research team from Aalto University has developed a new technique based on heating the tissue at the back of the eye using Near Infrared Light laser. The goal is to activate and strengthen the natural repair mechanisms in retinal cells before visual damage occurs that leads to blindness. The technique relies on stimulating cellular responses such as Heat Shock Proteins and the cellular self-cleaning mechanism (Autophagy), making it a promising strategy for early control of disease progression.
🧬 Age-Related Macular Degeneration: A Common and Vision-Threatening Health Condition
Age-related macular degeneration (AMD) is one of the leading causes of vision loss in older adults, affecting nearly one-third of people over the age of 80, and more than 20 million Americans over the age of 40 suffer from this disease.
The dry form of AMD is the most common and develops gradually, causing a decline in central vision, which is essential for clear visual tasks such as recognizing faces, reading, or driving.
Why is this important for health?
🧠 The underlying cause of visual decline in dry AMD
Increasing oxidative processes during aging damage proteins inside retinal cells, causing them to break apart and accumulate in the form of fatty deposits known as Drusen, which are the key diagnostic sign of this type of disease.
Drusen deposits affect retinal health, especially in the macula region, weakening central vision and increasing the likelihood of disease progression.
🩺 The new thermal laser technique: supporting cells rather than replacing them
Researchers at Aalto University examined an innovative strategy aimed at the early diagnostic stage, where the course of the disease can be slowed or altered before severe visual damage occurs.
Instead of trying to replace damaged cells after vision loss, this method relies on stimulating weak retinal cells to defend themselves and repair damage through a carefully controlled temperature effect.
Health takeaway
🧪 How it works: careful precision heating using Near Infrared Light
Near-infrared rays are used to precisely regulate and heat the tissues at the back of the eye by only a few degrees, without reaching temperatures above 45 degrees Celsius, which could cause tissue damage.
The system is distinguished by its ability to monitor temperature in real time, ensuring that heating remains within the safe range that allows retinal cells to activate their self-protective mechanisms.
🧬 Stimulating Heat Shock Proteins and the Autophagy mechanism
- Measured temperatures act as a stimulating signal or “heat shock” that prompts cells to produce Heat Shock Proteins, proteins that help fold damaged proteins correctly and protect them from harmful aggregation.
- If the repair process fails, these proteins break down misfolded proteins into amino acids that can be reused.
- The Autophagy mechanism is also activated, a cellular self-cleaning system that directs and breaks down damaged cellular components or foreign bodies, such as Drusen deposits.
These mechanisms are vital for maintaining the health of retinal cells, and the new technique focuses on reactivating them.
What did the research reveal?
🩸 Promising early results before human trials
The method was successfully tested in animal experiments on mice and pigs, demonstrating the ability to activate the required protective responses in retinal tissue without causing harm.
The researchers plan to begin clinical trials on humans in Finland during spring 2026, with the first phase focusing on evaluating safety rather than the extent of vision improvement or slowing disease progression.
The idea is based on the treatment being repeated to maintain the effectiveness of cellular responses, making it similar to a continuous maintenance system for the retina.
🌱 The broader context of research in dry AMD
This work comes amid a growing trend toward developing therapies based on stimulating tissues with light and thermal energy rather than replacing cells.
In the United States, the U.S. Food and Drug Administration approved the Valeda Light Delivery System, which relies on photobiomodulation technology, to improve visual acuity in selected dry AMD patients.
This medical landscape reveals increasing interest in treatments that rely on stimulating the body’s natural cellular mechanisms rather than traditional surgical or drug-based interventions.
Important scientific note
⚡ From discovery to clinics: a near future for dry AMD treatment
The results were published in Nature Communications in October 2025, and the researchers are working to turn the technique into a commercial product through a startup called Maculaser.
The scientific team expects the treatment could be available in eye clinics within three years, making it easily accessible to local ophthalmologists.
Although the method is still in the trial stage, activating cells using thermal laser technology may open a new horizon for treating dry macular degeneration by improving the defense capabilities of the retina before permanent damage appears.
📚 Related articles
Discover more from Mohdbali
Subscribe to get the latest posts sent to your email.
